Chad Zack, MD
Cardiovascular Disease · Hershey, PANPI 1073834388
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Medtronic at 51.8% of the total.
Across 101 payments — averaging $75.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Cardiovascular Systems Inc.$2K
- Abbott$1K
- Abiomed$199
- Boston Scientific$117
- Terumo Medical Corporation$113
- plus $261 from 6 others
Across 15 payments — averaging $5110.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- M.a. Med Alliance S.A.$77K
What the payments were for
- Travel & lodging$4,32857%
- Food & beverage$3,32843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 47 | $3,968 |
| Cardiovascular Systems Inc. | 14 | $1,525 |
| Abbott | 22 | $1,473 |
| Abiomed | 5 | $199 |
| Boston Scientific | 3 | $117 |
| Terumo Medical Corporation | 1 | $113 |
| Shockwave Medical, Inc | 2 | $103 |
| Atricure, Inc. | 1 | $45 |
| Philips North America LLC | 2 | $40 |
| Angiodynamics, Inc. | 1 | $40 |
| Teleflex LLC | 1 | $23 |
| Cvrx, Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,656 in reported general payments places this provider in the 80th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $61,054 |
| Repatha SureclickEvolocumab | 22 | $24,370 |
| BrilintaTicagrelor | 31 | $19,824 |
| FarxigaDapagliflozin Propanediol | 11 | $3,380 |
| Atorvastatin Calcium | 93 | $2,043 |
| Metoprolol Succinate | 110 | $1,771 |
| Rosuvastatin Calcium | 95 | $1,624 |
| Ezetimibe | 35 | $853 |
| ClopidogrelClopidogrel Bisulfate | 44 | $811 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 29 | $629 |
| Amlodipine Besylate | 59 | $479 |
| Potassium Chloride | 16 | $402 |
| Chlorthalidone | 23 | $299 |
| Furosemide | 57 | $297 |
| Metoprolol Tartrate | 24 | $231 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Hershey
- Gerald NaccarelliHershey$155K
- Sarah HussainHershey$59K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.